Bis(2,6-dioxopiperazines), catalytic inhibitors of DNA topoisomerase II, as molecular probes, cardiprotectors and antitumor drugs
- 31 March 1998
- Vol. 80 (3) , 235-246
- https://doi.org/10.1016/s0300-9084(98)80006-0
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- DNA Topoisomerase II as the Cellular Target of a Novel Antitumor Agent ICRF-193, a Bisdioxopiperazine Derivative, inXenopusEgg ExtractBiochemical and Biophysical Research Communications, 1997
- A postprophase topoisomerase II-dependent chromatid core separation step in the formation of metaphase chromosomes.The Journal of cell biology, 1995
- Synthesis of Simian Virus 40 C-family Catenated Dimersin Vivoin the Presence of ICRF-193Journal of Molecular Biology, 1995
- Inverse Relationship Between Catenation and Superhelicity in Newly Replicated Simian Virus 40 Daughter ChromosomesBiochemical and Biophysical Research Communications, 1994
- High resolution ordering of DNA markers by multi-color fluorescent in situ hybridization of prophase chromosomesCytogenetic and Genome Research, 1994
- Mode of action of topoisomerase II-targeting agents at a specific DNA sequence: Uncoupling the DNA binding, cleavage and religation eventsJournal of Molecular Biology, 1992
- Function of DNA topoisomerases as replication swivels in Saccharomyces cerevisiaeJournal of Molecular Biology, 1989
- DNA minor groove binding agents interfere with topoisomerase II mediated lesions induced by epipodophyllotoxin derivative VM-26 and acridine derivative m-AMSA in nuclei from L1210 cellsBiochemistry, 1989
- Synthesis and antitumor properties of N1-acyloxymethyl derivatives of bis(2,6-dioxopiperazines).CHEMICAL & PHARMACEUTICAL BULLETIN, 1989
- Antitumour Activity in a Series of bisDiketopiperazinesNature, 1969